Merit Medical Systems (NASDAQ:MMSI) Lowered to Buy at StockNews.com
Merit Medical Systems (NASDAQ:MMSI) Lowered to Buy at StockNews.com
StockNews.com lowered shares of Merit Medical Systems (NASDAQ:MMSI – Get Rating) from a strong-buy rating to a buy rating in a report issued on Monday morning.
在周一上午发布的一份报告中,斯托克新闻网将默立特医疗系统公司(纳斯达克代码:MMSI-GET Rating)的股票评级从买入下调至买入。
Other research analysts also recently issued reports about the company. Canaccord Genuity Group raised their price objective on Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. Piper Sandler increased their target price on Merit Medical Systems from $70.00 to $73.00 in a research report on Thursday, October 27th. Raymond James increased their target price on Merit Medical Systems from $71.00 to $72.00 and gave the company an outperform rating in a research report on Thursday, October 27th. TheStreet raised Merit Medical Systems from a c+ rating to a b- rating in a research report on Friday, September 16th. Finally, Canaccord Genuity Group cut Merit Medical Systems from a buy rating to a hold rating and dropped their target price for the company from $73.00 to $72.00 in a research report on Tuesday, December 20th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $73.50.
其他研究分析师最近也发布了关于该公司的报告。Canaccel Genuity Group在11月7日星期一的一份报告中将Merit Medical Systems的目标价从69.00美元上调至73.00美元。派珀·桑德勒在10月27日周四的一份研究报告中将其对Merit Medical Systems的目标价从70.00美元上调至73.00美元。Raymond James将Merit Medical Systems的目标价从71.00美元上调至72.00美元,并在10月27日周四的一份研究报告中给出了该公司表现优于大盘的评级。华尔街在9月16日星期五的一份研究报告中将Merit医疗系统的评级从C+上调至B-。最后,在12月20日星期二的一份研究报告中,Canaccel Genuity Group将Merit Medical Systems的评级从买入下调至持有评级,并将该公司的目标价从73.00美元下调至72.00美元。一位研究分析师对该股的评级为持有,五位分析师对该公司的评级为买入。根据MarketBeat的数据,该股目前的共识评级为适度买入,共识目标价为73.50美元。
Merit Medical Systems Trading Down 0.0 %
优点医疗系统公司股价下跌0.0%
Shares of NASDAQ MMSI opened at $70.85 on Monday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.19 and a current ratio of 2.35. The business's 50 day moving average price is $68.69 and its 200-day moving average price is $61.03. Merit Medical Systems has a fifty-two week low of $50.46 and a fifty-two week high of $76.14. The company has a market cap of $4.03 billion, a price-to-earnings ratio of 65.60, a PEG ratio of 2.51 and a beta of 1.02.
周一,纳斯达克微星的股价开盘报70.85美元。该公司的负债权益比率为0.19,速动比率为1.19,流动比率为2.35。该业务的50日移动均线价格为68.69美元,其200日移动均线价格为61.03美元。优点医疗系统公司的股价为50.46美元,为52周低点,52周高点为76.14美元。该公司市值为40.3亿美元,市盈率为65.60倍,聚乙二醇率为2.51倍,贝塔系数为1.02。
Institutional Trading of Merit Medical Systems
功勋医疗系统的制度性交易
A number of institutional investors have recently made changes to their positions in MMSI. Crossmark Global Holdings Inc. lifted its position in Merit Medical Systems by 4.2% during the 1st quarter. Crossmark Global Holdings Inc. now owns 5,212 shares of the medical instruments supplier's stock worth $346,000 after acquiring an additional 210 shares during the period. SG Americas Securities LLC lifted its position in Merit Medical Systems by 746.0% during the 2nd quarter. SG Americas Securities LLC now owns 27,013 shares of the medical instruments supplier's stock worth $1,466,000 after acquiring an additional 23,820 shares during the period. Rhumbline Advisers lifted its position in Merit Medical Systems by 8.8% during the 2nd quarter. Rhumbline Advisers now owns 143,882 shares of the medical instruments supplier's stock worth $7,808,000 after acquiring an additional 11,616 shares during the period. Maryland State Retirement & Pension System lifted its position in Merit Medical Systems by 1.4% during the 2nd quarter. Maryland State Retirement & Pension System now owns 20,671 shares of the medical instruments supplier's stock worth $1,122,000 after acquiring an additional 295 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in Merit Medical Systems by 17.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,337 shares of the medical instruments supplier's stock worth $235,000 after acquiring an additional 647 shares during the period. Institutional investors and hedge funds own 95.38% of the company's stock.
一些机构投资者最近改变了他们在MMSI的头寸。Crossmark Global Holdings Inc.在第一季度将其在Merit Medical Systems的头寸提高了4.2%。在此期间,Crossmark Global Holdings Inc.增持了210股,目前持有这家医疗器械供应商5,212股股票,价值346,000美元。第二季度,SG America Securities LLC将其在Merit Medical Systems的头寸提高了746.0%。在此期间,SG America Securities LLC额外收购了23,820股,目前拥有这家医疗器械供应商27,013股股票,价值1,466,000美元。Rhumbline Advisers在第二季度将其在Merit医疗系统公司的头寸提高了8.8%。在此期间,Rhumbline Advisers额外收购了11,616股,现在拥有143,882股这家医疗器械供应商的股票,价值7,808,000美元。马里兰州退休和养老金系统在第二季度将其在Merit医疗系统的地位提高了1.4%。马里兰州退休和养老金系统现在拥有这家医疗器械供应商的20,671股股票,价值1,122,000美元,在此期间又购买了295股。最后,NISA Investment Advisors LLC在第二季度将其在Merit Medical Systems的头寸提高了17.5%。NISA Investment Advisors LLC目前持有这家医疗器械供应商4337股股票,价值23.5万美元,在此期间又收购了647股。机构投资者和对冲基金持有该公司95.38%的股票。
Merit Medical Systems Company Profile
优点医疗系统公司简介
(Get Rating)
(获取评级)
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.
优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品,主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
- Southwest Airlines Stock, There is a Lot to Love
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
- 美光科技预计2023年底芯片回收
- 新年值得关注的三只医疗保健便士股
- 西南航空公司股票,有很多值得爱的东西
- MarketBeat:回顾一周12/19-12/23
- 这些钢铁制造商理应在2023年观察名单上占有一席之地
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。